Learn how AbbVie and Ironwood can help you save on LINZESS. Call 1-855-226-3937 or click to LEARN MORE ▸
- En Español
CHECK MY SYMPTOMS
CHECK MY SYMPTOMS
SEE IF YOU’RE ELIGIBLE TO SAVE ON LINZESS
SEE IF YOU’RE ELIGIBLE TO SAVE ON LINZESS
YOU COULD PAY AS LITTLE AS $30* FOR 90 OR 30 DAYS OF LINZESS
Whether you start with a 90-day or 30-day prescription, you could be eligible to pay as little as $30* with the LINZESS Savings Program. Talk to a doctor about a 90-day prescription to potentially maximize your savings and minimize trips to the pharmacy.
SIGN UP FOR TIPS & RESOURCES FOR LIVING WITH IBS-C
Get tips, resources, and more information about IBS-C and CIC, plus savings for commercially eligible patients on LINZESS right to your inbox.
Sign up
HOW DO I KNOW IF I’M ELIGIBLE TO SAVE ON LINZESS?
Find out if you’re eligible for the LINZESS Savings Program by signing up for a LINZESS savings card or activating an existing one.
NEED A SAVINGS CARD?
Text “LINZESS” to 59257** or call 1-855-859-5614 to sign up for the LINZESS Savings Program. After answering a few questions to confirm your eligibility, you’ll receive an activated LINZESS savings card.
-OR-
You can also sign up for the LINZESS Savings Program online. If you’re eligible, you’ll be able to download your activated savings card right away.
HAVE A SAVINGS CARD?
Activating a LINZESS savings card is easy: Just answer a few questions and provide your savings card number. If you’re eligible, your card will be ready instantly.
STAY ON TRACK WITH DAILY MEDICATION REMINDERS
Choose the time of day that works best for you, and you’ll receive a daily SMS text message to take LINZESS. Sign up today by texting “ENROLL” to 70128†.
Text ENROLL to 70128†
*Maximum savings limit applies; patient out-of-pocket expense may vary. This offer is available to patients with commercial insurance coverage and a valid LINZESS prescription. Offer not valid for patients enrolled in Medicare, Medicaid, or other federal or state healthcare programs. This offer is not valid for cash-paying patients. Please see Program Terms, Conditions, Privacy Notice, and Eligibility Criteria.
**By texting LINZESS to 59257, you will receive your activated savings card. 10 msgs. per enrollment activation. Message and data rates apply. Reply HELP for help; reply STOP to cancel. Consent not required to purchase goods/services. Please see full Terms and Privacy Policy.
†By texting ENROLL to 70128, you consent to receive automated and recurring text messages from From the Gut℠ regarding the From the Gut℠ program, including enrollment instructions, patient support communications and medication reminders, to the mobile number that you used to enroll. You are not required to consent or provide your consent as a condition of receiving any goods or services from From the Gut℠. Message and data rates may apply. You also agree to the additional Terms and Conditions.Click AbbVie Privacy Policy for additional information about AbbVie’s privacy practices or click Ironwood Privacy Policy for more information about Ironwood Pharmaceuticals’ privacy practices.
*Maximum savings limit applies; patient out-of-pocket expense may vary. This offer is available to patients with commercial insurance coverage and a valid LINZESS prescription. Offer not valid for patients enrolled in Medicare, Medicaid, or other federal or state healthcare programs. This offer is not valid for cash-paying patients. Please seeProgram Terms, Conditions, Privacy Notice, and Eligibility Criteria.
**By texting LINZESS to 59257, you will receive your activated savings card. 10 msgs. per enrollment activation. Message and data rates apply. Reply HELP for help; reply STOP to cancel. Consent not required to purchase goods/services. Please see fullTerms and Privacy Policy.
†By texting ENROLL to 70128, you consent to receive automated and recurring text messages from From the Gut℠ regarding the From the Gut℠ program, including enrollment instructions, patient support communications and medication reminders, to the mobile number that you used to enroll. You are not required to consent or provide your consent as a condition of receiving any goods or services from From the Gut℠. Message and data rates may apply. You also agree to the additionalTerms and Conditions. Click AbbVie Privacy Policy for additional information about AbbVie’s privacy practices or clickIronwood Privacy Policy for more information about Ironwood Pharmaceuticals’ privacy practices.
PROGRAM TERMS, CONDITIONS, AND ELIGIBILITY CRITERIA
This offer is valid only for patients with commercial prescription insurance coverage, who are 18 years ofage or older and meet eligibility criteria and is good for use only with a valid prescription for LINZESS®(linaclotide) capsules 72 mcg, 145 mcg, or 290 mcg at the time the prescription is filled by thepharmacist and dispensed to the patient. This offer is not valid for use by patients enrolled in Medicare,Medicaid, or other federal or state programs (including any state pharmaceutical assistance programs,TRICARE, Department of Defense or Veterans Affairs programs), or private indemnity or HMO insuranceplans that reimburse you for the entire cost of your prescription drugs or where prohibited by law or bythe patient’s health insurance provider. If at any time a patient begins receiving prescription drugcoverage under any such federal, state, or government-funded healthcare program, patient will nolonger be eligible to use the LINZESS savings card. Patients may not use this card if they are Medicare-eligible and enrolled in an employer-sponsored health plan or prescription drug benefit program forretirees. This offer is not valid for cash-paying patients. Offer good only in the USA, including PuertoRico, at participating retail pharmacies. Patients residing in or receiving treatment in certain states maynot be eligible to participate in this program. Depending on your insurance coverage, most eligiblepatients may pay as little as $30 per 30, 60, or 90-day supply for each of up to twelve (12) prescriptionfills per calendar year. One 60-day supply counts as two (2) fills and one 90-day supply counts as three(3) fills of the total twelve (12) fills. AbbVie reserves the right to rescind, revoke, or amend this offerwithout notice. Void if prohibited by law, taxed, or restricted. Patients may not seek reimbursem*nt forvalue received under the LINZESS Savings Program from any third-party payers. This offer is nottransferable. The selling, purchasing, trading, or counterfeiting of this card is prohibited by law. Thisoffer has no cash value and may not be used in combination with any other discount, coupon, rebate,free trial, or similar offer for the specified prescription. Subject to all other terms and conditions, themaximum annual benefit that may be available solely for the patient’s benefit under the co-payassistance program is $2,280.00 per calendar year. The actual application and use of the benefitavailable under the co-pay assistance program may vary on a monthly, quarterly, and/or annual basisdepending on each individual patient’s plan of insurance and other prescription drug costs. This offer isnot health insurance. By redeeming this offer, you acknowledge that you are an eligible patient and thatyou understand and agree to comply with the terms and conditions of this offer. To learn aboutAbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy.
HOW TO TAKE LINZESS
USES
LINZESS® (linaclotide) is a prescription medication used to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) in adults and functional constipation (FC) in children and adolescents 6 to 17 years of age. “Idiopathic” means the cause of the constipation is unknown. It is not known if LINZESS is safe and effective in children with functional constipation less than 6 years of age or in children with IBS-C less than 18 years of age.
IMPORTANT RISK INFORMATION
- Do not give LINZESS to children who are less than 2 years of age. It may harm them. LINZESS can cause severe diarrhea and your child could get severe dehydration (loss of a large amount of body water and salt).
- Do not take LINZESS if a doctor has told you that you have a bowel blockage (intestinal obstruction).
Before you take LINZESS, tell your doctor about your medical conditions, including if you are:
- Pregnant or plan to become pregnant. It is not known if LINZESS will harm your unborn baby.
- Breastfeeding or plan to breastfeed. You and your doctor should decide if you will take LINZESS and breastfeed.
Tell your doctor about all the medicines you take,including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Side Effects
LINZESS can cause serious side effects, including diarrhea, which is the most common side effect and can sometimes be severe. Diarrhea often begins within the first 2 weeks of LINZESS treatment. Stop taking LINZESS and call your doctor right away if you get severe diarrhea during treatment with LINZESS.
Other common side effects of LINZESS in people with IBS-C and CIC include gas, stomach-area (abdomen) pain, and swelling, or a feeling of fullness or pressure in your abdomen (distention).
Call your doctor or go to the nearest hospital emergency room right away if you develop unusual or severe stomach-area (abdomen) pain, especially if you also have bright red, bloody stools or black stools that look like tar.
These are not all the possible side effects of LINZESS. For more information, ask your doctor or pharmacist.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
If you are having difficulty paying for your medicine, AbbVie and Ironwood may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more.
US-LIN-230214
This information provided on this website is intended for U.S. healthcare professionals only.
I certify that I am a U.S. Healthcare Professional.
No
For adults with Irritable Bowel Syndrome with Constipation (IBS-C) or Chronic Idiopathic Constipation (CIC)
Answer a few quick questions about your symptoms.
Connect with a doctor online to find out if it could be IBS-C or CIC.
If approved, pick up your prescription from your local pharmacy.
*Third-party website; does not constitute an endorsem*nt or recommendation by AbbVie. A fee will be charged by the telemedicine provider.
Acknowledge and Continue
Cancel
You are now leaving LINZESS.com
By clicking “Acknowledge and Continue” above, you acknowledge and agree that neither AbbVie nor Ironwood does, in any way, endorse or recommend UpScript, a telemedicine provider, the qualifications of any physician associated with UpScript, or the quality of medical care any of those physicians can provide. You also acknowledge and agree that neither AbbVie nor Ironwood makes any guarantees that using UpScript will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential physician. AbbVie and Ironwood recommend that you meet and discuss the benefits and risks of all potential treatments with the potential physician. ABBVIE, IRONWOOD, AND THEIR RESPECTIVE AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE UPSCRIPT WEBSITE. If you agree to the above, click “Acknowledge and Continue” to proceed to the UpScript website. If you do not agree to the above, click “Cancel” to remain on LINZESS.com.
Did you know you can talk to a doctor today from the comfort of your home? Connect with a healthcare professional online about your symptoms.
NO THANKS
GET STARTED
Links to other websites are provided as a service to you. AbbVie and Ironwood Pharmaceuticals accept no responsibility for the content of other websites.
Would you like to continue?
No
Links to third-party content are provided as a convenience for informational purposes only. They are not meant to replace your healthcare provider’s medical advice or treatment. The organizations listed have not endorsed AbbVie and Ironwood or any of their respective products or services. AbbVie and Ironwood have listed these sites only as a convenience and according to the permissions granted by their respective terms of use. Each organization has its own terms and conditions and privacy policy that you should read if you choose to contact any of them.
Would you like to continue?
No
Transcript
You are leaving an AbbVie hosted website.
You are leaving the AbbVie website and connecting to a site that is not under the control of AbbVie. AbbVie is not responsible for the content of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply the endorsem*nt of the linked site by AbbVie. You should also be aware that the linked site may be governed by its own set of terms and conditions and privacy policy for which AbbVie has no responsibility.
Conversely, the presence of this link does not imply the linked site’s endorsem*nt of AbbVie.
Do you wish to leave this site?
No
US-LIN-230431-WOL
USES
LINZESS® (linaclotide) is a prescription medication used to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) in adults and functional constipation (FC) in children and adolescents 6 to 17 years of age. “Idiopathic” means the cause of the constipation is unknown. It is not known if LINZESS is safe and effective in children with functional constipation less than 6 years of age or in children with IBS-C less than 18 years of age.
IMPORTANT RISK INFORMATION
- Do not give LINZESS to children who are less than 2 years of age. It may harm them.LINZESS can cause severe diarrhea and your child could get severe dehydration (loss of a large amount of body water and salt).
- Do not take LINZESS if a doctor has told you that you have a bowel blockage (intestinal obstruction).
Before you take LINZESS, tell your doctor about your medical conditions, including if you are:
IMPORTANT RISK INFORMATION
- Do not give LINZESS to children who are less than 2 years of age. It may harm them.LINZESS can cause severe diarrhea and your child could get severe dehydration (loss of a large amount of body water and salt).
USES
LINZESS® (linaclotide) is a prescription medication used to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) in adults and functional constipation (FC) in children and adolescents 6 to 17 years of age. “Idiopathic” means the cause of the constipation is unknown. It is not known if LINZESS is safe and effective in children with functional constipation less than 6 years of age or in children with IBS-C less than 18 years of age.
IMPORTANT RISK INFORMATION
- Do not give LINZESS to children who are less than 2 years of age. It may harm them.LINZESS can cause severe diarrhea and your child could get severe dehydration (loss of a large amount of body water and salt).
- Do not take LINZESS if a doctor has told you that you have a bowel blockage (intestinal obstruction).
Before you take LINZESS, tell your doctor about your medical conditions, including if you are:
IMPORTANT RISK INFORMATION
- Do not give LINZESS to children who are less than 2 years of age. It may harm them.LINZESS can cause severe diarrhea and your child could get severe dehydration (loss of a large amount of body water and salt).
USES
LINZESS® (linaclotide) is a prescription medication used to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) in adults and functional constipation (FC) in children and adolescents 6 to 17 years of age. “Idiopathic” means the cause of the constipation is unknown. It is not known if LINZESS is safe and effective in children with functional constipation less than 6 years of age or in children with IBS-C less than 18 years of age.
IMPORTANT RISK INFORMATION
- Do not give LINZESS to children who are less than 2 years of age. It may harm them. LINZESS can cause severe diarrhea and your child could get severe dehydration (loss of a large amount of body water and salt).
- Do not take LINZESS if a doctor has told you that you have a bowel blockage (intestinal obstruction).
Before you take LINZESS, tell your doctor about your medical conditions, including if you are:
- Pregnant or plan to become pregnant. It is not known if LINZESS will harm your unborn baby.
- Breastfeeding or plan to breastfeed. You and your doctor should decide if you will take LINZESS and breastfeed.
Tell your doctor about all the medicines you take,including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Side Effects
LINZESS can cause serious side effects, including diarrhea, which is the most common side effect and can sometimes be severe. Diarrhea often begins within the first 2 weeks of LINZESS treatment. Stop taking LINZESS and call your doctor right away if you get severe diarrhea during treatment with LINZESS.
Other common side effects of LINZESS in people with IBS-C and CIC include gas, stomach-area (abdomen) pain, and swelling, or a feeling of fullness or pressure in your abdomen (distention).
Call your doctor or go to the nearest hospital emergency room right away if you develop unusual or severe stomach-area (abdomen) pain, especially if you also have bright red, bloody stools or black stools that look like tar.
These are not all the possible side effects of LINZESS. For more information, ask your doctor or pharmacist.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
If you are having difficulty paying for your medicine, AbbVie and Ironwood may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more.
US-LIN-230214
